486 related articles for article (PubMed ID: 1281075)
1. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
Murdoch D; McTavish D
Drugs; 1992 Oct; 44(4):604-24. PubMed ID: 1281075
[TBL] [Abstract][Full Text] [Related]
2. Sertraline: a new specific serotonin reuptake blocker.
Guthrie SK
DICP; 1991 Sep; 25(9):952-61. PubMed ID: 1949975
[TBL] [Abstract][Full Text] [Related]
3. The role of sertraline in the management of depression.
Shelton RC
Clin Ther; 1994; 16(5):768-82; discussion 767. PubMed ID: 7859236
[TBL] [Abstract][Full Text] [Related]
4. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
Grimsley SR; Jann MW
Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
[TBL] [Abstract][Full Text] [Related]
5. Sertraline: a new antidepressant.
Auster R
Am Fam Physician; 1993 Aug; 48(2):311-4. PubMed ID: 8342482
[TBL] [Abstract][Full Text] [Related]
6. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
7. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.
MacQueen G; Born L; Steiner M
CNS Drug Rev; 2001; 7(1):1-24. PubMed ID: 11420570
[TBL] [Abstract][Full Text] [Related]
8. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.
Alderman J; Wolkow R; Chung M; Johnston HF
J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):386-94. PubMed ID: 9549959
[TBL] [Abstract][Full Text] [Related]
9. Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
Chouinard G
Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():37-41. PubMed ID: 1484177
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of sertraline: a review.
Heym J; Koe BK
J Clin Psychiatry; 1988 Aug; 49 Suppl():40-5. PubMed ID: 3045112
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic management of obsessive-compulsive disorder.
Jackson CW; Morton WA; Lydiard RB
South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
[TBL] [Abstract][Full Text] [Related]
12. Sertraline and mental retardation with obsessive-compulsive disorder.
Wiener K; Lamberti JS
Am J Psychiatry; 1993 Aug; 150(8):1270. PubMed ID: 8328577
[No Abstract] [Full Text] [Related]
13. Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline.
Dodt JE; Byerly MJ; Cuadros C; Christensen RC
Am J Psychiatry; 1997 Apr; 154(4):582. PubMed ID: 9090357
[No Abstract] [Full Text] [Related]
14. Interactions between sertraline and tricyclic antidepressants.
Lydiard RB; Anton RF; Cunningham T
Am J Psychiatry; 1993 Jul; 150(7):1125-6. PubMed ID: 8317590
[No Abstract] [Full Text] [Related]
15. [The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
Kind B; Fattinger K; Krähenbühl S; Meier-Abt PJ
Praxis (Bern 1994); 1996 Nov; 85(46):1490-2. PubMed ID: 8984572
[TBL] [Abstract][Full Text] [Related]
16. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline.
Allen L; Tejera C
Am J Psychiatry; 1994 Jul; 151(7):1096-7. PubMed ID: 8010373
[No Abstract] [Full Text] [Related]
17. Obsessive-compulsive disorder: a new perspective in diagnosis and treatment.
Lydiard RB
Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():33-7. PubMed ID: 7963449
[TBL] [Abstract][Full Text] [Related]
18. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
Greist JH; Jefferson JW; Kobak KA; Chouinard G; DuBoff E; Halaris A; Kim SW; Koran L; Liebowtiz MR; Lydiard B
Int Clin Psychopharmacol; 1995 Jun; 10(2):57-65. PubMed ID: 7673657
[TBL] [Abstract][Full Text] [Related]
19. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.
Rasmussen S; Hackett E; DuBoff E; Greist J; Halaris A; Koran LM; Liebowitz M; Lydiard RB; McElroy S; Mendels J; O'Connor K
Int Clin Psychopharmacol; 1997 Nov; 12(6):309-16. PubMed ID: 9547132
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
Lydiard RB; Stahl SM; Hertzman M; Harrison WM
J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
